On August 9, the National Comprehensive Cancer Network (NCCN) announced the publication of a new set of guidelines for gestational trophoblastic neoplasia (GTN), also known as gestational trophoblastic disease (GTD), a group of rare cancers that can affect women during pregnancy. GTN can occur when tumors develop in the cells that would normally form the placenta during pregnancy. It affects approximately 1 out of every 1,000 pregnancies in the United States and is more common in many Asian and African countries. The NCCN Guidelines for GTN detail treatments for several variations of the disease.
Read the full NCCN press release here, and download this new guideline here.
Posted 8/9/2018
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
